Bolt Biotherapeutics, Inc. (BOLT) Free cash flow 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$39.9MFY2025 · since FY2020: -$50.6M → -$39.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.9M | +34.9% |
| FY2024 | -$61.3M | +12.0% |
| FY2023 | -$69.7M | +11.1% |
| FY2022 | -$78.5M | -32.1% |
| FY2021 | -$59.4M | -17.5% |
| FY2020 | -$50.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLT financial trends
BOLT RevenueBOLT Net incomeBOLT Net marginBOLT Gross profitBOLT Gross marginBOLT Operating incomeBOLT Operating marginBOLT Operating cash flowBOLT Capital expendituresBOLT Return on equityBOLT Stock buybacksBOLT Dividends paidBOLT Total assetsBOLT Total liabilitiesBOLT Shareholders’ equityBOLT overview →